Abstract:Neuropathic pain triggered by chemotherapy poses a significant clinical challenge. Investigating cell type-specific alterations through single-cell transcriptome analysis holds promise in understanding symptom development and pathogenesis. In this study, we performed single nuclei RNA (snRNA) sequencing of dorsal root ganglions (DRG) to explore the molecular mechanism underlying paclitaxel-induced neuropathic pain. Mouse exposed to repeated paclitaxel doses developed persistent pain hypersensitivity lasting at least 21 days. The snRNA sequencing unveiled seven major cell types within DRGs, with neurons further subdivided into 12 distinct subclusters using known markers. Notably, type C low-threshold mechanoreceptors (C_LTMR) exhibited the most pronounced transcriptomic changes post-paclitaxel administration. Differential gene expression and Gene Ontology (GO) analysis highlighted suppressed potassium-related currents, microtubule transport, and mitochondrial functions in C_LTMR following paclitaxel treatment. Meanwhile, Gene Set Enrichment Analysis (GSEA) suggested increased Interleukin 17 production in C_LTMR after paclitaxel exposure. Pseudo-time analysis uncovered nine distinct states (state 1 to 9) of C_LTMR. State 1 exhibits higher prevalence in paclitaxel-treated mice and altered neurotransmission properties, likely contributing to paclitaxel-induced pain hypersensitivity. This comprehensive exploration sheds light on the molecular mechanisms driving paclitaxel-induced neuropathic pain, offering potential avenues for therapeutic intervention.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is chemotherapy - induced peripheral neuropathy (CIPN), especially paclitaxel - induced neuralgia. Specifically, the study aims to deeply understand the molecular mechanisms of paclitaxel - induced neuralgia through single - nucleus RNA sequencing technology, in order to provide new ideas and methods for the prevention and treatment of CIPN. ### Research Background and Objectives Chemotherapy drugs such as paclitaxel often cause peripheral neuropathy while treating cancer, manifested as numbness, abnormal sensations, and increased pain sensitivity to mechanical and temperature stimuli. This side effect seriously affects the patient's quality of life and the continuity of treatment. At present, the mechanism of CIPN is not fully understood, and effective clinical management strategies are lacking. Therefore, this study uses single - nucleus RNA sequencing technology to explore cell - type - specific changes in paclitaxel - induced neuralgia to reveal its underlying molecular mechanisms. ### Main Findings 1. **Behavioral Tests**: - Mice repeatedly administered paclitaxel showed persistent mechanical hyperalgesia, thermal hyperalgesia, and cold hyperalgesia. 2. **Single - Nucleus RNA Sequencing**: - The sequencing results showed that there are seven main cell types in the dorsal root ganglion (DRG), among which neurons are further subdivided into 12 subgroups. - In particular, C - type low - threshold mechanoreceptors (C_LTMR) showed the most significant transcriptomic changes after paclitaxel treatment. 3. **Differential Gene Expression and Functional Enrichment Analysis**: - Differential gene expression analysis showed that potassium - related currents, microtubule transport, and mitochondrial function in C_LTMR were inhibited. - Gene set enrichment analysis (GSEA) indicated that C_LTMR increased the production of interleukin - 17 (IL - 17) after paclitaxel treatment. 4. **Pseudo - time Analysis**: - Pseudo - time analysis revealed nine different states (states 1 to 9) of C_LTMR, among which state 1 was more common in paclitaxel - treated mice and showed altered neurotransmission properties, which may be related to paclitaxel - induced hyperalgesia. ### Conclusions This study, through single - nucleus RNA sequencing technology, has detailedly analyzed the molecular mechanisms of paclitaxel - induced neuralgia, especially the key role of C_LTMR in this process. These findings not only enhance the understanding of CIPN but also provide new targets and directions for the development of targeted treatment strategies.

Single-Nuclei RNA Sequencing Identifies Type C Low-Threshold Mechanoreceptors as Key Players in Paclitaxel-Induced Peripheral Neuropathy

Single-cell RNA Sequencing in the Context of Neuropathic Pain: Progress, Challenges, and Prospects.

NFATc2-dependent epigenetic upregulation of CXCL14 is involved in the development of neuropathic pain induced by paclitaxel

Transcriptome analysis of microRNAs, circRNAs, and mRNAs in the dorsal root ganglia of paclitaxel-induced mice with neuropathic pain

Single-cell RNA sequencing uncovers the excitatory/inhibitory synaptic unbalance in the retrosplenial cortex after peripheral nerve injury

Temporal Changes of Spinal Transcriptomic Profiles in Mice With Spinal Nerve Ligation.

Proteomic Analysis of Dorsal Root Ganglia in a Mouse Model of Paclitaxel-Induced Neuropathic Pain

Circadian regulation of chemotherapy-induced peripheral neuropathic pain and the underlying transcriptomic landscape

DNMT3b SUMOylation Mediated MMP-2 Upregulation Contribute to Paclitaxel Induced Neuropathic Pain

Transcriptome Profiling of miRNA-mRNA Interactions and Associated Mechanisms in Chemotherapy-Induced Neuropathic Pain

Dynamic Long-Term Microstructural and Ultrastructural Alterations in Sensory Nerves of Rats of Paclitaxel-Induced Neuropathic Pain

Evaluation of Modified Fenton procedure for persistent superficial dyspareunia following childbirth

Paclitaxel Inhibits KCNQ Channels in Primary Sensory Neurons to Initiate the Development of Painful Peripheral Neuropathy

Glutamatergic Neurons in the Amygdala Are Involved in Paclitaxel-Induced Pain and Anxiety

Schwann Cell-Derived CXCL2 Contributes to Cancer Pain by Modulating Macrophage Infiltration in a Mouse Breast Cancer Model

Phosphate NIMA-Related Kinase 2-Dependent Epigenetic Pathways in Dorsal Root Ganglion Neurons Mediates Paclitaxel-Induced Neuropathic Pain

Roles of Thermosensitive Transient Receptor Channels TRPV1 and TRPM8 in Paclitaxel-Induced Peripheral Neuropathic Pain

Neuroimaging uncovers neuronal and metabolic changes in pain modulatory brain areas in a rat model of chemotherapy-induced neuropathy – MEMRI and ex vivo spectroscopy studies

Protein Arginine Methyltransferase 5 Contributes to Paclitaxel-Induced Neuropathic Pain by Activating Transient Receptor Potential Vanilloid 1 Epigenetic Modification in Dorsal Root Ganglion

Chemotherapy-induced peripheral neuropathy in a dish: dorsal root ganglion cells treated in vitro with paclitaxel show biochemical and physiological responses parallel to that seen in vivo

TET1 overexpression attenuates paclitaxel-induced neuropathic pain through rescuing K2p1.1 expression in primary sensory neurons of male rats